HIV vaccine
The near death — and last-minute reprieve — of a trial for an HIV vaccine
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would be over before it started.
A promising new HIV vaccine was set to start trials. Then came Trump’s latest cuts
On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine development program will end next year.
